Position in NVO
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$479,400
+$111,900 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#723
of 1,348 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLEN INVESTMENT GROUP, LTD. holds $51,757,200 across 9 Drug Manufacturers - General names. NVO ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
110,982 | $14,261,187 | |
| 2 | LLY |
ELI LILLY & Co
|
11,647 | $13,969,762 | |
| 3 | NVS |
Novartis AG
|
55,534 | $8,703,288 | |
| 4 | JNJ |
Johnson & Johnson
|
24,881 | $6,319,027 | |
| 5 | ABBV |
AbbVie Inc.
|
12,865 | $3,237,348 | |
| 6 | AMGN |
Amgen Inc
|
7,730 | $2,799,187 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
12,730 | $1,608,308 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
10,000 | $479,400 |
All Filings in NVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,400 | 10,000 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $367,500 | 10,000 | Shares | Sole | 2026-04-09 | |
| No filing history on record for this holder in this stock. | ||||||